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Summary
Objective: To investigate whether the development of osteoarthritic lesions in the knee joints of mice is associated with increased
immunostaining of type X collagen.
Methods: Sections of total knee joints in combination with immunohistochemistry were used to study the distribution of type X collagen in the
cartilage of young and old mice of two mouse strains, Balb/c and C57Bl/6, known to develop osteoarthritic lesions at different locations.
Expression of type X collagen and PTH/PTHrP-receptor mRNA were studied by RT-PCR.
Results: Young adult Balb/c and C57Bl/6 mice both expressed type X collagen in the non-calcified cartilage of the tibia-femoral joint. Old mice
of both strains had a strongly increased deposition of type X collagen in the patella-femoral but not in the tibia-femoral joint. The locations
in the murine knee joints prone to develop osteoarthritis (OA) did not preferentially express increased amounts of type X collagen. Thus,
whereas increased type X was observed in both strains in the patella-femoral joints, only Balb/c mice preferentially developed osteoarthritic
lesions in these joints. Also cartilage degeneration was usually seen only in the lateral compartment of the knee joints of C57Bl/6 mice but
this was not accompanied by increased type X collagen immunostaining. Increased deposition of type X collagen was not associated with
elevated levels of type X collagen mRNA or with decreased levels of PTH/PTHrP-receptor mRNA.
Conclusion: Type X collagen expression and spontaneous OA in mice are not necessarily related since OA prone locations in the murine
knee joint do not preferentially express type X collagen. © 2001 OsteoArthritis Research Society International
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Articular cartilage, covering the ends of long bones,
ensures almost frictionless movements of the articulating
surfaces. All the structural constituents necessary to per-
form the specific functions of articular cartilage, such as
collagens and proteoglycans, are synthesized by articular
chondrocytes. Aberrations in cartilage homeostasis due
to disfunctioning of articular chondrocytes will lead to
impairment of cartilage maintenance and eventually to
osteoarthritis (OA).
Terminal differentiation of chondrocytes (hypertrophy)
has been suggested to be involved in the OA process.
Hypertrophy of chondrocytes is characterized by expres-
sion of type X collagen, a homotrimer of 1(X) chains
ordinarily not expressed in non-calcified articular cartilage.92Hypertrophic chondrocytes and type X collagen are
typically located in the growth plates and calcified
articular cartilages1–3. However, limited expression of type
X collagen outside these sites has been reported4,5. Under
pathological conditions, such as human and experimen-
tal OA, strong expression of type X collagen is found
in articular chondrocytes derived from non-calcified
cartilage6–10. Moreover, chondrocyte hypertrophy and col-
lagen type X expression in the growth plate is associated
with increased matrix degradation and loss of type II
collagen11. Similar changes are known to occur during OA.
Therefore the processes involved in chondrocyte hyper-
trophy and OA may have features in common and might
share overlapping regulatory pathways.
A molecule involved in the regulation of chondrocyte
hypertrophy is parathyroid hormone-related peptide
(PTHrP). In the growth plate the transition of pre-
hypertrophic chondrocytes to hypertrophic chondrocytes is
suppressed by PTHrP12,13. During the differentiation of
growth plate chondrocytes from proliferating chondrocytes
to hypertrophic chondrocytes, the cells express an inter-
mediate phenotype, the pre-hypertrophic chondrocyte.
These cells express indian hedgehog (ihh) and the PTH/
PTHrP-receptor. It has been suggested that under the
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ANIMALS
Male C57Bl/6 and Balb/c mice aged 10–12 weeks
(young adult, N=14–16) and 1–2 years (old, N=14–16)
were used for histological studies. Expression of mRNA
was studied in male C57Bl/6 mice aged 3, 6, 10 and 18
months and in male Balb/c mice of 3, 6, 8 and 16 months.
The animals were kept in cages with wood chip bedding in
air-conditioned rooms at a constant temperature. They
were fed a standard laboratory diet and had access to
water ad libitum.HISTOLOGY
Young adult and old mice were killed by cervical disloca-
tion. Carefully dissected knee joints were fixed in phos-
phate buffered formaline (pH 7.4) for 5 days, decalcified
and processed in a standard automatic tissue processing
apparatus. Knee joints were embedded in paraffin wax and
coronal sections were prepared and stained with safranin O
and fast green.IMMUNOLOCALIZATION OF TYPE X COLLAGEN
Type X collagen was stained with a polyclonal rabbit
antibody developed by one of the co-authors (TM). This
antibody was raised against a human NC1 synthetic pep-
tide unique for type X collagen. The human and mouse
sequences of this peptide have only a single amino acid
difference. In earlier studies it was shown that the type X
collagen polyclonal antibody specifically stained type X
collagen in murine joints17. This antibody did not show
cross-reactivity against collagen type I, II, IX and XI.
Knee joints were dissected in toto and decalcified in 10%
EDTA (Merck, Darmstadt, Germany), 7.5% polyvinylpyrro-
lidone (PVP M 29.000, Serva, Amsterdam, The Nether-
lands) in 0.1 M Tris HCl (pH 7.4) for 2 weeks at 4°C. After
extensive washing of the joints with 7.5% PVP in 0.1 M
TrisHCl, knee joints were frozen in liquid nitrogen and
stored at −80°C. Coronal section (7 m) were cut on a
cryostat and mounted on microscope slides pre-coatedwith 3-aminopropyltriethoxy-silane (Sigma, St Louis, MO).
Sections were dried and stored at −80°C until use.
After thawing the sections were fixated for 5 min in 4%
formaldehyde (Sigma). To enhance the permeability of the
sections, extracellular matrix chondroitin sulfate and
hyaluronic acid were removed by incubation with 1%
hyaluronidase (type I-s, Sigma) for 30 min at 37°C.
Endogenous peroxidase was then blocked with freshly
prepared 1% (v/v) H2O2 in absolute methanol for 30 min at
room temperature. Non-specific staining was blocked by
pre-incubation of the sections with 10% normal goat serum
in PBS with 1% bovine serum albumin (Sigma). The
sections were incubated overnight with the anti-type X
collagen antibody (dilution 1:4000), followed by incubation
with the biotinylated secondary anti-rabbit immunoglobulin
antibody (dilution 1:400) whereafter the remainder of the
staining procedure was performed with a biotin-streptavidin
detection system (Vectra elite kit, Vectra, Burlington, CA).ISOLATION OF RNA FROM MURINE PATELLAR CARTILAGE
RNA was isolated from fresh patellar cartilage as
described18,19. In short, patellae were dissected from
murine knee joints and immediately decalcified at 4°C in
3.5% EDTA (Sigma) for 16 h. Following decalcification the
complete articular cartilage layer was stripped from the
underlying bone. Total RNA was isolated using the RNeasy
method as described by the supplier (Qiagen Inc, Valencia,
CA, USA). In all RT-PCR experiments, cartilages from 10
patellae were pooled.REVERSE TRANSCRIPTASE PCR
The RNA isolated from the cartilage was treated with
DNAse I (Life Technologies Inc) to remove possible con-
tamination of the samples with genomic DNA according to
the suppliers instructions. The reverse transcription (RT)
reaction was performed at 39°C with moloney-murine
leukemia virus (M-MLV) reverse transcriptase (Life
Technologies Inc) using oligo(dT)15 primers (Eurogentic,
Liege, Belgium). Amplification of cDNA was accomplished
by using Taq DNA polymerase (Life Technologies Inc) up to
a maximal cycle number of 40. To estimate the relative
mRNA levels, 5 l samples were taken at increasing cycle
numbers at two cycle intervals. The PCR products were
electrophoresed in 1.5% agarose gels containing ethidium
bromide. The cycle number at which the product was first
detected was taken as a measure for the amount of specific
mRNA. In the case of estimation of collagen mRNA levels,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA levels were used as an internal control. Due to the
limited amount of tissue and consequently RNA quantities,
measurement of the amount of total RNA was impossible.
All RT-PCR reactions were performed in duplicate. The
results are expressed as relative mRNA levels whereby the
expression in 3-month-old animals was arbitrarily set at 1.
The primers used in the amplification reactions were
the following. Primers detecting murine type X collagen had
the sequences 5′-ATACCCTTTCTGCTGCTAATGTTCTTG
ACC-3′ (upper, gene position 1663-1692) and 5′-TGATA
TTCCTGGTGGTCCTGGCAAC-3′ (lower, gene position
5349-5373) resulting in a product of 387 bp. Primers
detecting murine PTHrP/PTH-receptor had the following
sequences 5′-ATGATGGCAACAAAAAATCC-3′ and 5′-GG
TGTCCACTACACCGTCTT-3′ resulting in a product ofinfluence of ihh derived from the pre-hypertrophic
chondrocytes the neighbouring periarticular perichondrium
produces PTHrP, which then signals back to the pre-
hypertrophic cells and prevents transition to complete
hypertrophy12–15. In articular chondrocytes the role of
PTHrP in the regulation of chondrocyte phenotype is
unclear. However, PTHrP and PTHrP-receptor have been
demonstrated in articular chondrocytes, which could imply
a role for these molecules in the regulation of chondrocyte
phenotype not only in the growth plate but also in articular
cartilage16.
The goal of this study was to investigate whether the
development of osteoarthritic lesions in the knee joints of
aged mice is associated with expression of type X collagen
at these lesion sites. Since elevated immunostaining of
type X collagen was indeed observed in these ageing mice
we additionally evaluated whether this increased immuno-
staining correlated with increased expression of type X
collagen mRNA and concomitant down-regulation of the
expression of PTHrP-receptor mRNA.
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AAGATTGTCAGCA-3′ and 5′-TCCACCACCCTGTTGGC
TGTA-3′ were used (product 553 bp). Primer sequences
were selected with the computer programs Primer
(Whitehead Institute, Cambridge, MA) and oligo 4.0
(National Biosciences, Plymouth, MN) and sequence data
from international data banks.Results
With the exception of articular cartilage as described
below, immunostaining of type X collagen was found only in
association with hypertrophic chondrocytes, e.g. the growth
plate, at the interface of bone and tendons and in calcified
articular cartilage. In the growth plate, proliferating and
resting zone chondrocytes were completely negative for
type X collagen staining while pronounced staining was
observed around the hypertrophic chondrocytes (Fig. 1).
Omission of the first antibody resulted in complete absence
of staining.IMMUNOSTAINING OF TYPE X COLLAGEN IN YOUNG BALB/C AND
C57BL/6 MICE
Cartilage degeneration and type X collagen immuno-
staining in non-calcified cartilage in young and old mice are
summarized in Table I. In the young (10–12 weeks old)
Balb/c and C57Bl/6 mice cartilage lesions were absent. All
cartilage surfaces were intact and there was no depletion
of proteoglycans revealing the absence of cartilage
degeneration in the knee joints of these young animals
[Fig. 2(B),(D),(F)]. In the patella-femoral joint of young
Balb/c and C57Bl/6 mice, type X collagen immunostain-
ing was found in the calcified cartilage [Figs 2(A) and
3(A)]. Type X collagen staining was present pericellularly
surrounding the hypertrophic chondrocytes. Occasionally
a faint band of type X collagen immunostaining was seen
at the cartilage surface in the central part of the femur
[Fig. 3(A)]. The number of hypertrophic chondrocytes was
higher and the layer of calcified cartilage thicker in the
Balb/c than in the C57Bl/6 mice.
In contrast, on both the lateral and the medial side of the
tibia-femoral joint, type X collagen was clearly observed in
the non-calcified cartilage [Figs 2(C),(E) and 3(B),(C)]. All
chondrocytes in the calcified cartilage stained with the type
X antibody. Enlarged chondrocytes with a hypertrophic
appearance expressing type X collagen were present
above the tidemark in the zone of non-calcified cartilage
[Figs 2(E) and 3(B)]. In addition a number of small chondro-
cytes also stained for type X collagen [Figs 2(C),(E) and
3(C)]. Besides the pericellular immunostaining, a band of
type X collagen staining was present at the cartilage
surface. No difference in type X collagen staining was
observed between the medial and the lateral side of
tibia-femoral joint [Figs 2(C),(E) and 3(B),(C)].Fig. 1. Staining for type X collagen in the growth plate of young Balb/c mice. Only the hypertrophic chondrocytes in the murine growth plate
showed strong type X collagen staining while the proliferating and the resting zone chondrocytes were completely negative (A—type X
collagen staining, B—safranin O staining, original magnification 100×).Table I
Expression of cartilage degeneration and type X collagen expres-
sion in the non-calcified articular cartilages in young and old Balb/c
and C57Bl/6 mice
Joint Type X collagen
expression
Cartilage
degeneration
Young Old Young Old
Balb/c
Patella/femoral − + + + − + +
Tibia/femoral
Medial + + + + − −/+
Lateral + + + + − −
C57Bl/6
Patella/femoral − + + + − −
Tibia/femoral
Medial + + + + − −/+
Lateral + + + + − + + +
Type X collagen expression; − absent, + light, + + moderate,
+ + + pronounced. Cartilage degeneration; − absent, + light, + +
moderate, + + + severe.OA LESIONS AND IMMUNOSTAINING OF TYPE X COLLAGEN IN OLD
MICE
Both old Balb/c and C57Bl/6 mice developed cartilage
degeneration. However, the location of osteoarthritic
lesions was different between the mouse strains. The
Balb/c mice preferentially developed osteoarthritic lesions
in the patella-femoral joint (60% of the knee joints) while the
C57Bl/6 strain showed osteoarthritic lesions mainly on the
Osteoarthritis and Cartilage Vol. 9, No. 2 95Fig. 2. Type X collagen immunolocalization and safranin O staining in the knee joints of young adult Balb/c mice. Note the almost total
absence of type X collagen staining in the non-calcified cartilage of the patella-femoral joint (except sometimes at the articular cartilage
surface) and the presence in the tibia-femoral joint. The cartilage surface of young Balb/c mice was intact in all compartments (A, B
patella-femoral joint; C, D lateral side tibia-femoral joint; E, F medial side tibia femoral joint; A, C, E type X collagen; B, D, F safranin O;
original magnification PF-joint 100× , TF-joint 200×).lateral side of the tibia-femoral joint (63% of the knee joints)
as can be seen in Figs 4(B) and 5(D). The osteo-
arthritic lesions were characterized by fibrillations and
erosions of the non-calcified cartilage extending up to the
tidemark. In animals with very severe lesions the calcified
cartilage was also affected.
Type X collagen immunostaining in the patella-femoral
joint was pronounced in the old mice compared with
young mice of both strains, although only the Balb/c micedeveloped osteoarthritic lesions in this compartment
[compare Figs 2(A) and 3(A) with Figs 4(A) and 5(A)]. In
the young mice, staining was almost totally confined to the
calcified cartilage but in the old mice type X collagen
immunostaining was at least as high in the non-calcified
cartilage as in the calcified. The staining in the calcified
cartilage appeared to be mainly pericellular while the stain-
ing in the non-calcified cartilage of old mice was more
widespread and present throughout the cartilage matrix.
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cartilage damage, as could be seen in the C57Bl/6 strain
compared to Balb/c mice. No increased type X collagen
immunostaining was observed in sites of degeneration and
loss of articular cartilage.
Although the lateral side of the tibia-femoral joint of
C57Bl/6 mice preferentially develops OA like lesions, no
preferential increase in type X collagen staining could be
observed in the degenerate cartilage on the lateral tibialplateau of old C57Bl/6 mice [Fig. 5(C)]. Moreover, the type
X collagen staining on the lateral side of the tibia-femoral
joint was comparable with the staining on the medial side of
this joint in the C57Bl/6 mice [Fig. 5(C), (E)]. Also, the type
X collagen immunostaining in the Balb/c mice in the tibia-
femoral joint was not less pronounced than the staining in
C57Bl/6 mice [Fig. 4(C), (E)]. In the tibia-femoral joint
neither the old Balb/c nor the old C57Bl/6 mice showed
enhanced immunostaining of type X collagen compared to
young mice.EXPRESSION OF TYPE X COLLAGEN AND PTHRP-RECEPTOR MRNA
IN CARTILAGE OF YOUNG AND OLD MICE
Since a striking increase in type X collagen immuno-
staining was observed in the patella-femoral joint of old
mice compared to young mice, expression of type X
collagen mRNA and PTHrP-receptor mRNA was investi-
gated in murine patellar cartilage of various ages. Notwith-
standing the profound increase in type X collagen in the
patellar cartilage, as detected by immunohistochemistry, no
increase in type X collagen mRNA expression could be
detected in old animals (Fig. 6). Moreover, no changes in
the expression of PTHrP-receptor mRNA were found in
mice from the various age groups (Fig. 6).Fig. 3. Type X collagen immunolocalization in the knee joints of
young adult C57Bl/6 mice. Note the absence of type X collagen
staining in the non-calcified cartilage of the patella-femoral joint
and the presence in the tibia-femoral joint (A, patella-femoral
joint; B, lateral side tibia-femoral joint; C, medial side tibia femoral
joint, original magnification PF-joint 100×, TF-joint 200×).Discussion
In both young and old Balb/c and C57Bl/6 mice type X
collagen could be detected not only at the expected sites
known to contain hypertrophic chondrocytes but also in the
non-calcified cartilage of the tibia-femoral joint. During
aging there appeared to be an increased deposition of type
X collagen particularly in the patella-femoral compartment
but not in the tibia-femoral joint. Only in Balb/c mice was
cartilage degeneration preferentially expressed in the
patella-femoral joint. Moreover, in C57Bl/6 mice degenera-
tion was seen preferentially in the lateral compartment of
the tibial-femoral joint, a site with no increased type X
immunostaining. Thus there was no relationship between
type X collagen immunostaining and degeneration in non-
calcified cartilage.
Expression of type X collagen is suggested to be a
specific marker for chondrocyte hypertrophy and in healthy
articular cartilage it is thought to be confined to the calcified
zone, although earlier studies have observed type X colla-
gen deposition on the surface of articular cartilage4.
Our results clearly show that in articular cartilage of
young (tibia-femoral joint) and old mice (predominantly
patella-femoral joint) type X collagen could be detected in
non-calcified cartilage. The type X collagen enveloped
chondrocytes were partly large chondrocytes, with a hyper-
trophic phenotype based on cell size. But small chondro-
cytes were also surrounded by type X collagen. However,
no chondrocytes in the non-calcified cartilage stained for
alkaline phosphatase (data not shown) indicating that the
chondrocytes in this zone do not express all the features of
a hypertrophic phenotype. These observations indicate that
the expression of type X collagen in the mouse is not totally
confined to hypertrophic chondrocytes.
The distribution of type X collagen in murine articular
cartilage reported in this study appears to be similar to the
pattern reported by Eerola et al.5 These authors, who only
showed data for the tibia-femoral joint, detected type X
collagen immunostaining in very young mice mainly in the
Osteoarthritis and Cartilage Vol. 9, No. 2 97Fig. 4. Type X collagen immunolocalization and safranin O staining in the knee joints of old Balb/c mice. Note the strong type X collagen
staining in the non-calcified cartilage of the patella-femoral joint and the presence of cartilage degeneration in this joint. (A, B, patella-femoral
joint; C, D, lateral side tibia-femoral joint; E, F, medial side tibia femoral joint; A, C, E, type X collagen; B, D, F, safranin O; original
magnification PF-joint 100×, TF-joint 200×).transitional zone, and also in 3-month-old mice in the
superficial zone. In contrast with our results, Eerola et al.
observed the most intense staining in the tidemark area.
This difference in staining pattern could be due to differ-
ences between the antibodies, either raised against recom-
binant type X collagen (Eerola) or a NC1 domain synthetic
peptide. Moreover, differences between the mouse strains
used could also account for the small dissimilarities in
staining pattern.Type X collagen expression, as a marker for chondrocyte
hypertrophy, has been found in osteoarthritic cartilage and
chondrocytes for osteoarthritic cartilage6–10. The Balb/c
and C57Bl/6 mouse strains develop OA-like lesions in very
different locations in the knee joint, the patella-femoral joint
vs the lateral side of tibia-femoral joint, but appeared to
have a strikingly similar immunostaining pattern of type X
collagen in both young and old mice. Young mice of both
strains had almost no type X collagen immunostaining in
98 P. M. van der Kraan et al.: Expression of type X collagen in young and old miceFig. 5. Type X collagen immunolocalization and safranin O staining in the knee joints of old C57Bl/6 mice. Note the strong type X collagen
staining in the noncalcified cartilage of the patella-femoral joint and the absence of cartilage degeneration in this joint. The lateral side of the
tibia-femoral joint shows cartilage degeneration up to the tidemark (A, B patella-femoral joint; C, D lateral side tibia-femoral joint; E, F medial
side tibia-femoral joint; A, C, E type X collagen; B, D, F safranin O; original magnification PF-joint 100×, TF-joint 200×).the non-calcified cartilage of the patella-femoral joint, but
extensive staining was observed in this area in old mice,
although only the Balb/c mice develop OA in this location.
Moreover, old C57Bl/6 mice develop OA on the lateral side
of the tibia-femoral joint while no increased type X collagen
immunostaining was observed in old mice in this compart-
ment. These data appear to conflict with the results of
Eerola et al.5 using OA prone Del1 mice. Intense type Xcollagen staining was observed in these mice in areas with
surface fibrillation, osteophyte formation and degenerating
menisci. We also observed type X collagen staining in
osteophytes undergoing endochondral ossification, menisci
and calcifying ligaments (data not shown). However,
nonosteoarthritic joints of old mice also show meniscal
degeneration and ligament calcification and type X colla-
gen expression in these tissues. The cause of staining
*Osteoarthritis and Cartilage Vol. 9, No. 2 99differences with respect to the fibrillated surface of osteoar-
thritic cartilage remains obscure but might be related to
differences in antibodies or mouse strains used.
Although a relationship between type X collagen
immunostaining and OA development could not be found in
old mice, cartilage of the patella-femoral joint showed a
striking increase in type X collagen immunostaining in the
non-calcified cartilage of old mice. Therefore expression of
type X collagen and PTHrP-receptor mRNA was evaluated
with RT-PCR in patellar cartilage of mice with different
ages. Remarkably, in spite of the increased expression of
type X collagen at the protein level, no increase in type X
collagen mRNA could be detected. This observation is in
concordance with studies of Eerola et al.5 who found no
changes in type X collagen mRNA levels in mice from 3 to
9 months old. The absence of elevated mRNA levels might
indicate that the elevated immunostaining of type X colla-
gen is not due to continued elevated synthesis of this
molecule but may be caused in part by increased deposi-
tion and/or retention of type X collagen (at least the NCI
domain) in the cartilage matrix. In an earlier study it was
found that increased immunostaining of type X collagen in
non-calcified murine patellar cartilage after intra-articular
injection of papain was not accompanied by increased
expression of type X collagen mRNA17. The absence of
increased mRNA levels, the distribution of collagen type X
throughout the matrix and the observation that type X
collagen can diffuse long distances through chick carti-
lage20 suggest that increased deposition is the basis for the
enhanced immunostaining of type X collagen in patellar
cartilage. The observation that PTHrP-receptor mRNA is
not decreased in patellar cartilages of old mice indicates
that down-regulation of the PTHrP-receptor in articular
chondrocytes is not detectably involved in the increasedexpression of type X collagen as may be observed in the
growth plates12,13.
This study shows that young mice contain type X colla-
gen in the non-calcified cartilages of the tibia-femoral joint
but that type X collagen expression is almost absent in the
non-calcified cartilage of the patella-femoral joint at this
age. In old mice strongly increased expression is observed
in the patella-femoral joints but not in the tibia-femoral
joints. Locations in the murine joints of Balb/c and C57Bl/6
mice prone to development of OA do not preferentially
express type X collagen in the non-calcified cartilage
suggesting that type X collagen expression and OA
development are not necessarily related phenomena.Acknowledgment
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Fig. 6. Relative expression of type X collagen (A) and PTH/PTHrP-
receptor (B) mRNA in Balb/c and C57Bl/6 mice of various ages.
Samples were taken at increasing cycle numbers and the PCR
products were electrophoresed. The cycle number at which the
product was first detected was used for generating the results in
this figure. The expression of GAPDH in the same samples was
used as an internal control. The expression in the 3-month-old
animals was arbitrarily set at 1. In all RT-PCR experiments
cartilage of 10 patellae were pooled ( C57Bl/6,  Balb/c).References
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